HHS Secretary gives update on vaccine rollout

Health and Human Services Secretary Alex Azar defends the slower-than-anticipated distribution of the doses and speaks about any developments with the Oxford/AstraZeneca vaccine.
3:33 | 01/04/21

Coming up in the next {{countdown}} {{countdownlbl}}

Coming up next:



Skip to this video now

Now Playing:


Related Extras
Related Videos
Video Transcript
Transcript for HHS Secretary gives update on vaccine rollout
We're joined live by Alex Azar, the secretary of health and human services. Secretary, always appreciate you taking time with us, especially on the heels of Victor Oquendo's report right there. According to the CDC 13 million doses of the vaccine has been administered so far. That was less than the goal of 20 million. What are the reasons for the delay, sir? Robin, thanks for having me. You know, as you know the fda approved these vaccines in the days before Christmas. We said our goal was to have 20 million first doses available in the month of December. Those are available. There's a lag between doses available and being ordered by the providers in the states, shipping and vaccination, especially when you have Christmas and new year's in the middle. We've seen a rapid uptick in the last 72 hours. 1.5 additional add menstruations of the vaccine. I'm very hopeful we'll see a continued rapid uptick. As Dr. Fauci talked about, this is the largest vaccination campaign in the history of the United States. I'm surprised there haven't been more glitches. Our states are on it. We're working with the governors providing them help. It's promising what we've been seeing in recent days. I want to ask you about a couple strategies. One was to give half doses of the modern vaccines to some recipients. There was another strategy to give everyone one dose before being concerned about the second what do you think of those S as to the first idea regarding dose and dosing strategy, we go with the data and the science. The clinical trials which is the gold standard had add menstruation schedules and dosing requirements. That's what the data supports at the fda. If different data is generated supporting different dosing schedules and the fda approves it, that's what we'll do we'll stick with the data we've got. In terms of dosing a first dose without a second dose available, that's not on the label. That's not what the data supports, knowing you won't have a second dose. The data isn't there to support that. We're holding in reserve that second dose because we believe we need to go according to what the fda said is the safe and effective way to use the vaccines. What about additional vaccines? We saw in the uk they started to administer the oxford vaccines, along with two others. When do you feel the additional vaccines will be available in the U.S.? We could see data from the Johnson & Johnson vaccine which is a single-dose vaccine as well as the oxford vaccine any time now. Unfortunately we have so many cases in the United States. We don't want that. That speeds the vaccine clinical trials. We could see data any time. It will go to the fda for review and we initiated a fifth for we now have five. Secretary Azar, thank you for your time. I know everyone is working around the clock. Take care. Well, coming up we're

This transcript has been automatically generated and may not be 100% accurate.

{"duration":"3:33","description":"Health and Human Services Secretary Alex Azar defends the slower-than-anticipated distribution of the doses and speaks about any developments with the Oxford/AstraZeneca vaccine.","mediaType":"default","section":"ABCNews/GMA","id":"75032601","title":"HHS Secretary gives update on vaccine rollout","url":"/GMA/News/video/hhs-secretary-update-vaccine-rollout-75032601"}